Debates 2008
JANUARY
The Motion: Seminal-Nerve Sparing Radical Cystectomy is an Efficacious and Safe Treatment for Selected Bladder Cancer Patients
For: Colombo R
Against: Hautmann R E
MARCH
The Motion: At Least 18 Cores are Necessary to Make a Prostatic Biopsy Useful
For: de la Taille A
Against: Jones JS, Klein E
MAY
The Motion: All Men Over the Age of 50 Should be Encouraged to Take a 5 alpha Reductase Inhibitor to Prevent Prostate Cancer
For: Klotz L
Against: Clarke N
JULY
The Motion: Antimuscarinics are the Mainstay of Therapy for Overactive Bladder
For: Chapple C
Against: Cruz F
SEPTEMBER
Laser therapy for BPH is preferable to TURP
For: Bachmann A
Against: Marberger MJ
NOVEMBER
The Motion: Perioperative Chemotherapy in Muscle Invasive Bladder Cancer Improves Survival
For: Bellmunt J
Against: Hautmann R
Interviews 2007
JANUARY
Interview with Ulf Tunn:
LHRHa: What's new?
APRIL
Interview with Cora N. Sternberg:
Prostate Cancer Chemotherapy
JUNE
Interview with Richard Sylvester:
Transition Cell Carcinoma of the Bladder
AUGUST
Interview with Guido Barbagli:
Substitution Urethroplasty: Which Tissues and Techniques are Optimal for Urethral Replacement?
OCTOBER
Interview with François Giuliano
New Avenues in the Pharmacological Treatment of Premature Ejaculation
DECEMBER
Interview with Pierre Costa
Minimally Invasive Treatment of Female Stress Urinary Incontinence
Interviews 2006
JANUARY
Interview with Claude Schulman
MARCH
Interview with John Fitzpatrick:
Combination Therapy for BPH: Is This the Way Forward?
MAY
Interview with Chris Chapple:
Overactive Bladder: Tackling the Problem
JULY
Interview with Jack Schalken:
PCA3 and its Use as a Diagnostic Test in Prostate Cancer
SEPTEMBER
Interview with Per-Anders Abrahamson:
Angiogenesis and Renal Cell Carcin
NOVEMBER
Interview with Peter Albers:
Treatment Developments in Testicular Cancer
Debates 2007
FEBRUARY
The Motion: Open partial nephrectomy is the standard of care for small resectable solid renal masses
For: Kirkali Z
Against: Gill IS, Aron M
MARCH
The Motion: Large BPH Should be Treated by Open Surgery
For: Rigatti P, Cestari A
Against: Gilling P
MAY
The Motion: Radical Cystectomy in the Elderly is Becoming a Standard Treatment for Bladder Cancer
For: Brausi M A
Against: Whelan P
JULY
The Motion: A Robot is Needed to Perform the Best Nerve Sparing Prostatectomy
For: Artibani W, Ficarra V
Against: Guillonneau B D
SEPTEMBER
The Motion: Tapes and not Bulking Agents/Drugs are First-Line Treatment of SUI
For: Burkhard F C.
Against: Heesakkers J
NOVEMBER
The Motion: PDE5 Inhibitors Will Have a Significant Role in the Treatment of BPH
For: Kaplan S A
Against: Hatzichristou D
Debates 2006
FEBRUARY
The Motion: Prevention of Prostate Cancer with a 5?-Reductase Inhibitor is Feasible
For: Roehrborn CG , Lotan Y
Against: Tubaro A , de Nunzio C
APRIL
The Motion: There is a Role for Chronic Treatment with PDE5-Inhibitors
For: Heaton JPW
Against: Hatzichristou D
JUNE
The Motion: Surgery is the Best Choice for Peyronie's Disease
For: Ralph D
Against: Hauck EW
AUGUST
The Motion: There is Evidence That Prostate Cancer Screening Does More Good Than
For: Schröder FH
Against: Albertsen P
OCTOBER
The Motion: Injectables are Justified as a First Option for Stress Urinary Incontinence
For: Van Kerrebroeck P
Against: Corcos J
DECEMBER
The Motion: Surveillance is an Option for Renal Cancer
For: Jewett M A.S.
Against: Stöckle M
